fda tirzepatide obesity What Is Used for? Approved and Potential Uses Tirzepatide (ZEPBOUND) Approved for Chronic

Many patients assume medication failure signals a personal failure or lack of discipline

Serum proteomic analysis of major depressive disorder patients and their remission status: Novel biomarker set of zinc-alpha-2-glycoprotein and keratin type Ii cytoskeletal 1

van Bruggen, R

The study found a higher risk of NAION in patients prescribed GLP-1 compared to those on non-GLP-1 RA medications

This medicine, called Mounjaro and Zepbound, is approved by the FDA

The study, published in Proceedings of the National Academy of Sciences (PNAS), focuses on pancreatic ductal adenocarcinoma (PDAC), a highly aggressive cancer with a very low five-year survival rate